April 2010
Volume 51, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2010
Comparison of Rapamycin and Mitomycin for Reduction of Postoperative Fibrosis After Filtration Surgery in a Rabbit Model
Author Affiliations & Notes
  • M. M. Hermann
    Ophthalmology, University of Cologne, Koeln, Germany
  • B. Schröter
    Ophthalmology, University of Cologne, Koeln, Germany
  • M. Diestelhorst
    Ophthalmology, University of Cologne, Koeln, Germany
  • Footnotes
    Commercial Relationships  M.M. Hermann, None; B. Schröter, None; M. Diestelhorst, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science April 2010, Vol.51, 3199. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      M. M. Hermann, B. Schröter, M. Diestelhorst; Comparison of Rapamycin and Mitomycin for Reduction of Postoperative Fibrosis After Filtration Surgery in a Rabbit Model. Invest. Ophthalmol. Vis. Sci. 2010;51(13):3199.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose:
 

Postoperative fibrosis is a challenge for successful filtration surgery in glaucoma. Mitomycin C is widely used to modulate wound healing but is known to cause significant toxic effects on ocular tissue. Rapamycin (Sirolimus) has a known antifibrotic action on vascular endothelium und cultured human tenon fibroblasts. This study aimed at comparing the effects of Rapamycin and Mitomycin on postoperative fibrosis after filtration surgery in a rabbit model.

 
Methods:
 

24 rabbits (ChBB:CH) received a unilateral subconjunctival injections of Rapamycin (200µl, 1mg/ml) immediately after filtrating glaucoma surgery and 1 week after sugery. 24 control eyes received episcleral sponge application of 100 µl Mitomycin C (0.2 mg/ml, 4 min) during surgery. Antifibrotic efficacy was established by clinical response and histological examination. A bleb survival analysis based on IOP measurements was used to compare clinical response of Rapamycin and Mitomycine C. Sucessful filtration surgery was defined as a lowering of IOP by 4 mmHg or more from baseline. Baseline was assessed for each eye by repeated rebound tonometry before surgery. Animals were sacrificed four weeks after surgery for histological examination.

 
Results:
 

Mean baseline IOP was 19.7 ± 1.2 mmHg. Mean IOP one day after surgery was 10.5 ± 3.0 mmHg and did not differ significantly between eyes treated with Mitomycin or Rapamycin (t-test, p=0.27). Mean bleb survival (Kaplan Meier) was 24.7 ±1.1 days with Mitomycin and 23.7 ± 1.2 days with Rapamycin. The difference was insignificant (Log Rank test, p>0.5). Histological comparison of the surgical area using blind scoring revealed a milder fibrosis and a higher number of blood vessels in eyes treated with Rapamycin (Mann-Whitney-U-Test, p<0.05).

 
Conclusions:
 

Rapamycin showed an antifibrotic efficiency comparable to Mitomycin in this animal model for filtration surgery. Rapamycin is a promising approach to control postoperative fibrosis in patients undergoing filtration surgery. Whether a sufficient long-term effect in human eyes using repeated subconjunctival injections of Rapamycin can be achieved remains to be elucidated.  

 
Keywords: wound healing • anterior segment • clinical laboratory testing 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×